Could NSW go its own way on codeine?
Rules around pharmacist vaccinations differ between states – and the same could happen for codeine availability, one stakeholder says With only two days to go before low-dose codeine is upscheduled …
Women with Type 2 diabetes lose CVD protection
People with diabetes are twice as likely to suffer sudden cardiac death, a new report shows Released by the Baker Heart and Diabetes Institute, The Dark Heart of Type 2 …
Research Roundup
Debbie Rigby rounds up the latest in research news Update on colchicine, 2017 Colchicine is currently approved for the treatment of gout. Studies indicate that it may be beneficial in …
Letter to the editor: Upschedule is about protecting patients
Response to article published in the AJP – OTC codeine death claims must stop by A/Prof Adrian Reynolds The Australian Journal of Pharmacy article with Pharmacy Guild NSW Branch president …
No GP S8 prescription ban: TGA
There is no substance to reports that GPs could be banned from prescribing S8 analgesics, the TGA says Over the long weekend, Fairfax and News media reported that the TGA’s …
Students shine at pharmacy conference
Good vibes and dance moves took centre stage at the NAPSA Congress Ball, with top members awarded for their dedication and enthusiasm Early last week pharmacy students descended upon Sydney …
Staff Spotlight
AJP chats with Matthew Scott, who has recently transitioned from intern to fully fledged pharmacist at Alfred Health in Melbourne 1. How have you found the transition from intern to pharmacist …
New social media videos on codeine
ScriptWise has launched new videos on social media as the February 1st codeine rescheduling deadline looms Codeine will become prescription-only this Thursday following the Therapeutic Goods Administration’s decision that the …
My Health Record consultation begins
Consultation has started on the My Health Record Guidelines for Pharmacists developed by the PSA The Guidelines provide guidance to pharmacists on meaningful clinical use of the My Health Record …
Professional disagreement
New pharmacy pain program a “slap in the face” for GPs: AMA The AMA has reacted angrily to the announcement of the $20 million pharmacy Pain MedsCheck trial, claiming it …
Five tips for smarter money decisions in 2018
You shouldn’t take your foot off the pedal even if you feel your financial situation is under control, as mistakes can be easily made, says Jonathan Philpot, wealth management expert People …
Pain trial ‘a great move forward’
The $20 million Pain MedsCheck trial is about ensuring pharmacy is at the frontline of primary care, says Greg Hunt Last week, the Health Minister announced a Pain MedsCheck trial, …